Table 1.
Parameter | Overall Sample (n=114) | |
---|---|---|
Frequency (n) | Percentage (%) | |
Gender | ||
Female | 65 | 57 |
Male | 49 | 43 |
Age group of patients | ||
Age, years, Mean (SD) | 66.84 (12.3) | |
18 to 64 | 43 | 37.7 |
65 to 74 | 38 | 33.3 |
≥75 | 33 | 28.9 |
Highest education level | ||
No formal Education | 85 | 74.6 |
Below SLC | 20 | 17.5 |
SLC and above | 9 | 7.9 |
Duration since AF diagnosis | ||
Less than 2 years | 46 | 40.4 |
More than 2 years | 68 | 59.6 |
Employment status | ||
Employed | 7 | 6.1 |
Unemployed | 107 | 93.9 |
Smoking | ||
Yes | 3 | 2.6 |
No | 34 | 29.8 |
Ex-smoker | 77 | 67.5 |
Alcohol | ||
Yes | 2 | 1.8 |
No | 48 | 42.1 |
Exdrinker | 64 | 56.1 |
CHA2DS2VASC RISK | ||
CHA2 DS2 VASC score Mean(SD) | 2.58 (1.42) | |
Low risk (0) | 6 | 5.3 |
Intermediate risk (1) | 24 | 21.1 |
High risk (≥2) | 84 | 73.7 |
HASBLED RISK | ||
HASBLED score Mean (SD) | 0.96 (0.775) | |
Low risk (0) | 34 | 29.8 |
Moderate risk (1–2) | 78 | 68.4 |
High risk (≥3) | 2 | 1.8 |
BMI of patients | ||
Severely underweight (< 16.5 kg/m^2) | 3 | 2.6 |
Underweight (16.5–18.5 kg/m^2) | 6 | 5.3 |
Normal weight (18.5 to 24.9 kg/m^2) | 58 | 50.9 |
Obesity (≥30 kg/m^2) | 47 | 41.2 |
AF Type | ||
Valvular AF | 17 | 14.9 |
Non Valvular AF | 97 | 85.1 |
AF Type | ||
Unknown | 94 | 82.5 |
Paroxysmal AF | 17 | 14.9 |
Permanent AF | 1 | 0.9 |
Persistent AF | 2 | 1.8 |
Category of drug used | ||
No antithrombotic therapy | 4 | 3.5 |
OAC therapy | 93 | 81.6 |
Antiplatelet therapy | 17 | 14.9 |
Comorbidities | ||
Rheumatic heart Disease | 26 | 22.8 |
COPD | 29 | 25.4 |
Acute Kidney Injury | 8 | 7.0 |
Other comorbidities | 63 | 55.3 |
Congestive heart failure(Signs/symptoms of heart failure or objective evidence of reduced left ventricular ejection fraction) | 35 | 30.7 |
Dyslipidemia | 4 | 3.5 |
Carotid Artery Disease | 6 | 5.3 |
Hypothyroidism | 14 | 12.3 |
Hypertension(Resting BP >140/90 mmHg on at least two occasions or current antihypertensive treatment) fraction | 45 | 39.5 |
Age (65–74 yrs) | 38 | 33.3 |
Age ≥ 75yrs | 33 | 28.9 |
Diabetes mellitus(Fasting glucose >125 mg/dL (7 mmol/L) or treatment with oral hypoglycemic agent and/or insulin) | 16 | 14.0 |
Prior stroke, transient ischemic attack, or Thromboembolism | 14 | 12.3 |
Stroke | 12 | 10.5 |
Bleeding history/Predisposition(anemia) | 9 | 7.9 |
Elderly (>65yr) | 71 | 62.3 |
Antiplatelet therapy | 15 | 13.2 |
Abbreviations: AF, atrial fibrillation; CHA2DS2VASC, congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism (doubled), vascular disease, age 65 to 74 years, sex category; HASBLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (.65 years), Drugs/alcohol concomitantly; BMI, Body Mass Index; OAC, Oral Anticoagulants; COPD, Chronic Obstructive Pulmonary Disease.